Have Surgical Outcomes of Pathologic T4 Esophageal Squamous Cell Carcinoma Really Improved? Analysis of 268 Cases During 45 Years of Experience

Journal of the American College of Surgeons

Volumn 206, Issue 1, 2008, Pages 48-56

  Shimada, Hideaki ^a   Shiratori, Tooru ^a   Okazumi, Shinichi ^a   Matsubara, Hisahiro ^a   Nabeya, Yoshihiro ^a   Shuto, Kiyohiko ^a   Akutsu, Yasunori ^a   Hayashi, Hideki ^a   Isono, Kaichi ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; EVALUATION RESEARCH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 37249019562     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.06.013     Document Type: Article

References (21)

1. Akiyama H., Tsurumaru M., Udagawa H., and Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220 (1994) 364-373
2. Altoki N., Kent M., Ferrara C., and Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
3. Shimada H., Okazumi S., Matsubara H., et al. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 30 (2006) 1441-1449
4. Shimada H., Kitabayashi H., Nabeya Y., et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 133 (2003) 24-31
5. Ichiyoshi Y., Kawahara H., Taga S., et al. Indications and operative techniques for combined aortoesophageal resection. Jpn J Thorac Cardiovasc Surg 47 (1999) 318-324
6. Ancona E., Ruol A., Castoro C., et al. First line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus. Ann Surg 226 (1997) 714-724
7. Tsujinaka T., Shiozaki H., Yamamoto M., et al. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg 177 (1999) 503-506 discussion 507
8. Matsubara T., Ueda M., Kokudo N., et al. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. Eur J Surg 25 (2001) 279-284
9. Fujita H., Sueyoshi S., Tanaka T., et al. Esophagectomy: Is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer?. Prospective nonrandomized trial comparing chemotherapy with surgery versus without surgery. World J Surg 29 (2005) 25-31
10. Brucher B.L.D.M., Becker K., Lordick F., et al. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinoma. Cancer 106 (2006) 2119-2127
11. th ed (2002), John Wiley & Sons, New York
12. th ed: Preface, general principles, part I. Esophagus 1 (2004) 61-88
13. Hoshino T., Shimada H., Miyazaki S., et al. Three dimensional endoscopic ultrasonography was useful to evaluate response to chemo-radiotherapy in esophageal cancer. Chiba Med J 81 (2005) 39-45
14. Tohma T., Okazumi S., Makino H., et al. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology 52 (2005) 486-490
15. Iizuka T., Ide H., Kakegawa T., et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 93 (1988) 1054-1058
16. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 104 (1993) 203-207
17. Ando N., Iizuka T., Kakegawa T., et al. A randomized trial of surgery with and without chemotherapy for localized squamous cell carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study. J Thoracic Cardiovasc Surg 114 (1997) 205-209
18. Ando N., Iizuka T., Ide H., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 24 (2003) 4592-4596
19. Okazumi S., Ochiai T., Shimada H., et al. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 17 (2004) 159-163
20. Shimada H., Ochiai T., Okazumi S., et al. Clinical benefits of steroid on the surgical stress in patients with esophageal cancer. Surgery 128 (2000) 791-798
21. Shimada H., Okazumi S., Matsubara H., et al. Impact of steroid therapy on postoperative course and survival in patients with thoracic esophageal carcinoma. Esophagus 1 (2004) 89-94